Comment on 'Androgens and Women: COVID-19 Outcomes in Women with Acne Vulgaris, Polycystic Ovarian Syndrome, and Hirsutism'

    Ayman Abdelmaksoud, Mohamad Goldust, Michelangelo Vestita
    Studysummary This review discusses the relationship between hyperandrogenic conditions like PCOS and COVID-19, noting that while hyperandrogenic women have varied hospitalization rates, they do not show increased mortality, and suggests isotretinoin as a potential therapeutic option for cutaneous symptoms.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on onlinelibrary.wiley.com →
    Discuss this study in the Community →

    Research cited in this study 1

    1. Clinical Symptoms of Hyperandrogenic Women Diagnosed with COVID-19 Journal of the European Academy of Dermatology and Venereology · 2020

    Related research 5

    1. Spironolactone in Dermatology: Uses in Acne, Hidradenitis Suppurativa, Female Pattern Hair Loss, and Hirsutism Actas Dermo-Sifiliográficas · 2020
    2. Managing the PCOS-Related Symptoms of Hirsutism, Acne, and Hair Loss Springer eBooks · 2013
    3. Polycystic Ovary Syndrome and Acne Skin therapy letter · 2011
    4. Ovarian Morphology and Prevalence of Polycystic Ovary Syndrome in Reproductive Aged Women With or Without Mild Acne International Journal of Dermatology · 2010
    5. Hormonal Therapy for Acne: Why Not as First Line Therapy? Facts and Controversies Clinics in Dermatology · 2009